Prevalence of and Risk Factors for Lipoatrophy in Patients with HIV Infection in Nigeria

Table 5

Logistic regression of factors predicting the development of lipoatrophy in the patients with HIV infection.

Variable	Odds ratio	95% CI	value
Host factor
Age	1.03	0.99–1.07	0.15
Gender (male/female)	4.34	2.29–8.23	<0.001^*
Treatment factor
HAART use (yes/no)	2.31	1.12–4.73	0.03^*
Disease factor
CD4 count (mm^3)	1.00	1.00-1.00	0.09
Viral load (copies/mL); <200/>200	1.76	1.03–3.00	0.46
Known duration of HIV; infection	1.03	0.53–2.00	0.94

CI: confidence interval; ^*statistically significant.